Cstone Pharmaceuticals
Clinical trials sponsored by Cstone Pharmaceuticals, explained in plain language.
-
New hope for lung cancer: targeted pill tested after other treatments fail
Disease control OngoingThis phase 2 trial is testing the drug lorlatinib in about 70 Chinese patients with advanced ROS1-positive non-small cell lung cancer that has worsened after prior treatments (crizotinib and chemotherapy). The goal is to see how many patients respond to the drug and how long the …
Phase: PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New immunotherapy combo aims to fight advanced liver cancer
Disease control OngoingThis phase 3 study tests whether adding nofazinlimab (an immunotherapy) to lenvatinib (a standard targeted therapy) helps people with advanced liver cancer live longer. About 534 participants who have not had prior systemic treatment will receive either the combo or a placebo plu…
Phase: PHASE3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC